In summary, FTY720 is a potent immunosuppressive agent that is well tolerated in patients. Due to its mode of action, which differs substantially from that of other known immunosuppressive drugs, and due to its different side effect profile, FTY720 is a promising partner in immunosuppressive regimens and will substantially extend the standard immunosuppressive repertoire. © ERA-EDTA 2004; all rights reserved.
CITATION STYLE
Kunzendorf, U., Ziegler, E., & Kabelitz, D. (2004, June). FTY720 - The first compound of a new promising class of immunosuppressive drugs. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfh295
Mendeley helps you to discover research relevant for your work.